Literature DB >> 18717856

Xanthelasma palpebrarum and its relation to atherosclerotic risk factors and lipoprotein (a).

Sevil Ozdöl1, Sedef Sahin, Lale Tokgözoğlu.   

Abstract

OBJECTIVES: To investigate the association between xanthelasma, atherosclerotic risk factors, and lipoprotein (Lp) (a), and to determine whether xanthelasma may be a cutaneous marker for atherosclerosis.
METHODS: One hundred consecutive patients with xanthelasma and 100 age- and sex-matched patients without xanthelasma, seen during the same time period (controls), were included in this study. The prevalence of cardiac risk factors, the rates of atherosclerotic disease, Framingham risk scores, and Lp (a) levels were compared between the patient groups.
RESULTS: Hyperlipidemia was found to be significantly more common in patients with xanthelasma (P = 0.001); however, the rate of clinically overt cardiovascular disease and future cardiovascular risk, assessed by the Framingham risk score, were similar between the groups. No significant difference was observed in serum Lp (a) levels between the groups.
CONCLUSIONS: In patients with xanthelasma, no increase was observed in the rate or risk of cardiovascular disease. Moreover, no relationship was found between Lp (a) levels and xanthelasma.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18717856     DOI: 10.1111/j.1365-4632.2008.03690.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  10 in total

1.  Periorbital Hyperpigmentation in Patients with Xanthelasma Palpebrarum: An Interesting Observation.

Authors:  Eftychia Platsidaki; Anargyros Kouris; Efthymia Agiasofitou; Christina Antoniou; Georgios Kontochristopoulos
Journal:  J Clin Aesthet Dermatol       Date:  2016-04-01

2.  Serum lipid profile and clinical characteristics of patients with xanthelasma palpebrarum.

Authors:  Hossein Kavoussi; Ali Ebrahimi; Mansour Rezaei; Mazaher Ramezani; Behnaz Najafi; Reza Kavoussi
Journal:  An Bras Dermatol       Date:  2016 Jul-Aug       Impact factor: 1.896

3.  Xanthelasma palpebrarum associated with increased cardio-ankle vascular index in asymptomatic subjects.

Authors:  Ali Rıza Akyüz; Turhan Turan; Musluhittin Emre Erkuş; İsmail Gürbak; Selim Kul; Levent Korkmaz; Mustafa Tarık Ağaç; Şükrü Çelik
Journal:  Wien Klin Wochenschr       Date:  2016-03-14       Impact factor: 1.704

4.  Outcomes of surgical management of xanthelasma palpebrarum.

Authors:  Hoon Young Lee; Ung Sik Jin; Kyung Won Minn; Young-Oh Park
Journal:  Arch Plast Surg       Date:  2013-07-17

5.  The Significance of Extracellular Cholesterol Crystals or a Cholesterol Granuloma in Xanthelasma.

Authors:  Frederick A Jakobiec; Lina Ma; Natalie Wolkow; Francis C Sutula; Suzanne K Freitag
Journal:  Ocul Oncol Pathol       Date:  2018-02-21

6.  Xanthelasmata, arcus corneae, and ischaemic vascular disease and death in general population: prospective cohort study.

Authors:  Mette Christoffersen; Ruth Frikke-Schmidt; Peter Schnohr; Gorm B Jensen; Børge G Nordestgaard; Anne Tybjærg-Hansen
Journal:  BMJ       Date:  2011-09-15

7.  Familial xanthelasma with dyslipidemia: just another family trait?

Authors:  Shridhar Dwivedi; Amitesh Aggarwal; Safal Singh; Vishal Sharma
Journal:  N Am J Med Sci       Date:  2012-05

Review 8.  Xanthelasma palpebrarum - a brief review.

Authors:  Pragya A Nair; Rochit Singhal
Journal:  Clin Cosmet Investig Dermatol       Date:  2017-12-18

Review 9.  Skin disease related to metabolic syndrome in women.

Authors:  Angelica Misitzis; Paulo R Cunha; George Kroumpouzos
Journal:  Int J Womens Dermatol       Date:  2019-07-04

10.  Risk of Non-Alcoholic Fatty Liver Disease in Xanthelasma Palpebrarum.

Authors:  Ying-Hsuen Wu; Yi-Lin Chiu; Hsuan-Wei Chen; Jung-Chun Lin
Journal:  J Inflamm Res       Date:  2021-05-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.